Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PPX and Concurrent Radiation for Newly Diagnosed Glioblastoma Without MGMT Methylation: A Randomized Phase II Study

NCT01402063 is registered in ClinicalTrials.gov with Brown University as lead sponsor.

NCT NCT01402063
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01402063 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PPX and Concurrent Radiation for Newly Diagnosed Glioblastoma Without MGMT Methylation: A Randomized Phase II Study
Lead sponsor
Brown University
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2011
Completion date
June 30, 2015
Enrollment
63 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

glioblastoma multiforme